Pharmacoeconomic Evaluation
P. T. Nagaraju
, P. B. Indu
Pharmacoeconomics, cost effective analysis, cost utility analysis, cost benefit analysis, health care decision making, economic evaluation.
Pharmacoeconomic evaluation is the assessment of the cost-effectiveness, cost-utility, or cost-benefit of pharmaceutical interventions, aiming to optimize the allocation of healthcare resources. It plays a crucial role in decision-making processes by comparing the costs and health outcomes of different therapeutic options. Pharmacoeconomic studies provide insights into the value of new drugs or treatment strategies in comparison to existing alternatives, enabling healthcare policymakers, providers, and patients to make informed choices.
These evaluations are typically categorized into four main types: cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-benefit analysis (CBA), and cost-minimization analysis (CMA). CEA compares the costs and health outcomes (often measured in quality-adjusted life years, or QALYs) between competing interventions. CUA specifically incorporates quality of life in its analysis, giving weight to both the quantity and quality of life gained. CBA, in contrast, assigns monetary value to both the costs and the health outcomes. CMA is used when two or more interventions are equivalent in terms of outcomes, with the primary comparison being the cost.
In addition to these traditional methods, pharmacoeconomics also incorporates sensitivity analysis to account for uncertainty in the assumptions and data used. It helps in identifying the most cost-effective treatment options, particularly when resources are limited. Ultimately, pharmacoeconomic evaluations guide the development of healthcare policies, reimbursement decisions, and patient care strategies, ensuring that the maximum benefit is achieved from the available healthcare budgets. This is especially relevant in the context of rising healthcare costs and the growing burden of chronic diseases globally.
"Pharmacoeconomic Evaluation", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.10, Issue 10, page no.a805-a811, October-2025, Available :https://ijsdr.org/papers/IJSDR2510093.pdf
Volume 10
Issue 10,
October-2025
Pages : a805-a811
Paper Reg. ID: IJSDR_305287
Published Paper Id: IJSDR2510093
Downloads: 00026
Research Area: Pharmacy All
Country: Kurnool, Andhrapradesh, India
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave
